Sanofi to publish COVID-19 vaccine price in development with GSK after Phase I/II trial results
The logo of Sanofi is seen at the company's headquarters in Paris, France, April 24, 2020.
REUTERS/Charles PlatiauPARIS - French drug maker Sanofi will announce the price of the potential COVID-19 vaccine it is developing with Britain's GlaxoSmithKline after it has released Phase I/II results of the trials, vaccines chief Thomas Triomphe said on Thursday.
The company is expected to release the results from the Phase I/II clinical trials this month.
It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.
(Reporting by Matthias Blamont in Paris; Writing by Josephine Mason in London; Editing by Jon Boyle) ((Josephine.Mason@thomsonreuters.com; +44 207 542 7695; Reuters Messaging: josephine.mason.reuters.com@reuters.net))
More From Business
